+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 670 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5706929
The Medical Devices sector report, “Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Clinical Chemistry pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clinical Chemistry segment comprises of reagents, test kits and electrodes which aid in determining the concentration or activity of biomolecules, such as protein, carbohydrate, lipid, enzyme, minerals or other small molecules.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Clinical Chemistry under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clinical Chemistry and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clinical Chemistry under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Clinical Chemistry Overview
3 Products under Development
3.1 Clinical Chemistry - Pipeline Products by Stage of Development
3.2 Clinical Chemistry - Pipeline Products by Segment
3.3 Clinical Chemistry - Pipeline Products by Territory
3.4 Clinical Chemistry - Pipeline Products by Regulatory Path
3.5 Clinical Chemistry - Pipeline Products by Estimated Approval Date
3.6 Clinical Chemistry - Ongoing Clinical Trials
4 Clinical Chemistry - Pipeline Products under Development by Companies
4.1 Clinical Chemistry Companies - Pipeline Products by Stage of Development
4.2 Clinical Chemistry - Pipeline Products by Stage of Development
5 Clinical Chemistry Companies and Product Overview6 Clinical Chemistry - Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Clinical Chemistry - Pipeline Products by Stage of Development
  • Clinical Chemistry - Pipeline Products by Segment
  • Clinical Chemistry - Pipeline Products by Territory
  • Clinical Chemistry - Pipeline Products by Regulatory Path
  • Clinical Chemistry - Pipeline Products by Estimated Approval Date
  • Clinical Chemistry - Ongoing Clinical Trials
  • Clinical Chemistry Companies - Pipeline Products by Stage of Development
  • Clinical Chemistry - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Clinical Chemistry - Pipeline Products by Stage of Development
  • Clinical Chemistry - Pipeline Products by Segment
  • Clinical Chemistry - Pipeline Products by Territory
  • Clinical Chemistry - Pipeline Products by Regulatory Path
  • Clinical Chemistry - Pipeline Products by Estimated Approval Date
  • Clinical Chemistry - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 20/20 GeneSystems Inc
  • 2invest AG
  • A.Menarini Diagnostics Ltd
  • A/C Diagnostics LLC
  • Abbott Diagnostics
  • Abreos Biosciences Inc (Inactive)
  • ADA Technologies, Inc.
  • Adaptive Biotechnologies Corp
  • Advanced Biological Laboratories SA
  • Affinergy LLC
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Alfa Wassermann Inc
  • Analyticon Biotechnologies AG
  • AnaZyme LLC
  • Angle Biosciences Inc
  • Animated Dynamics Inc
  • Ap Lifesciences LLC
  • Applied Research using OMIC Sciences SL
  • Arizona State University
  • ARK Diagnostics Inc
  • Astrego Diagnostics AB
  • Augurix SA
  • AutoGenomics Inc
  • Avacta Group Plc
  • Base Pair Biotechnologies Inc
  • Becton Dickinson and Co
  • BG Medicine Inc
  • Biocross SL
  • Bioftalmik Applied Research
  • BIOHOPE Scientific SL
  • BioMarin Pharmaceutical Inc
  • Bio-Rad Laboratories Inc
  • Biostarks Labs US Inc
  • Biotech Resources Aust Pty Ltd
  • Bisu Inc
  • Boditech Med Inc
  • Boston University
  • Burnet Institute
  • California Pacific Medical Center Research Institute
  • Calmark Sweden AB
  • Cambridge Diagnostic Imaging Ltd
  • Cambridge Nutranostics Ltd
  • Carclo Diagnostic Solutions Ltd
  • CardioGenics Inc
  • CCC Diagnostics LLC
  • Cellex Inc
  • Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
  • Centre Hospitalier Universitaire de Nice
  • Charite University Hospital of Berlin
  • Chemeleon Inc
  • China Sky One Medical Inc
  • Chromanostics Inc
  • Chronix Biomedical Inc
  • Claremont BioSolutions
  • Clemson University
  • Clinical Design Technologies Ltd
  • Cognizance Biomarkers LLC
  • Columbia University
  • ContraVac Inc (Inactive)
  • CytoVas LLC
  • Denovo Biolabs Pvt Ltd
  • DiaSys Diagnostic Systems GmbH
  • DNAPrint Genomics Inc (Inactive)
  • DoacLevel
  • Dublin City University
  • Ecole Polytechnique Federale de Lausanne
  • Edan Instruments Inc
  • EKF Diagnostics Holdings Plc
  • ELITechGroup Inc
  • Eone Diagnomics Genome Center Co Ltd
  • Eurobio Scientific SA
  • First Light Diagnostics Inc
  • Fluoresprobe Sciences LLC
  • Foundation for Innovative New Diagnostics
  • Gene Express, Inc. (Inactive)
  • genedrive plc
  • GenMark Diagnostics Inc
  • Giner Inc
  • GlucoSentient Inc
  • Group K Diagnostics
  • Guangzhou Wondfo Biotech Co Ltd
  • Healthmed Services Ltd. (Inactive)
  • Healthy io Ltd
  • Horiba Ltd
  • Imperial College London
  • In Vitro Diagnostic Solutions Inc
  • Indian Institute of Technology Delhi
  • Inflammatix Inc
  • Insilixa, Inc.
  • Instrumentation Laboratory Co
  • IPI Singapore
  • IR2Dx Inc.
  • IRIS International Inc
  • iXensor Co. Ltd.
  • Johns Hopkins University
  • Kalium Health Ltd
  • KIYATEC Inc
  • Kobe University
  • Kwandong University College of Medicine
  • L’epigeneMD Co Ltd
  • Laboratorios Rubio SA
  • LifeAssays AB
  • LumiraDx Ltd
  • Magee-Womens Research Institute
  • Massachusetts Institute of Technology
  • Medical Research Council
  • Medical University of South Carolina
  • Metabolon Inc
  • Miami VA Healthcare System
  • MiCo BioMed Co Ltd
  • Monash University
  • Montana State University
  • Mylab Discovery Solutions Pvt Ltd
  • Myotherapeutics LLC (Inactive)
  • NanoSpeed Diagnostics Inc
  • Newcastle University
  • Nipro Europe N.V.
  • Northeastern University
  • NTBIO Diagnostics Inc
  • Nuclea Biotechnologies Inc. (Inactive)
  • Ohmx Corp
  • OPKO Health Inc
  • Overture Life Inc
  • Oxford Immunotec Ltd
  • PanGenomic Health Inc
  • Pax Neuroscience Inc
  • Pelago Bioscience AB
  • Pennsylvania State University
  • Plateletdiagnostics LLC
  • PortaScience Inc
  • Predict Health LLC
  • Prediction Sciences LLC (Inactive)
  • PreventionGenetics LLC
  • Primogen Biotech Pvt Ltd
  • ProciseDx LLC
  • Progenika Biopharma SA
  • PrognosDx Health Inc
  • Prometheus Laboratories Inc
  • Proteomika (Inactive)
  • Purdue University
  • Qiagen NV
  • QSTAG Co Ltd
  • Queen Mary University of London
  • Quidel Corp
  • Raptamer Discovery Group LLC
  • redhot diagnostics AB
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • Rockland Immunochemicals Inc
  • SAGA Diagnostics AB
  • Saladax Biomedical Inc
  • SaltCheck Inc (Inactive)
  • Seattle Children's Hospital
  • Sebia
  • SenGenix Inc
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Shilpa Medicare Ltd
  • Siemens Healthcare Diagnostics Inc
  • Singapore General Hospital
  • Sirius Genomics Inc
  • Spanish National Research Council
  • Specto Srl
  • SpinChip Diagnostics AS
  • SQI Diagnostics Inc
  • Stanford University
  • SuperNova Diagnostics, Inc.
  • Systagenix Wound Management Ltd
  • T2 Biosystems Inc
  • Teco Diagnostics
  • TestCard Ltd
  • The Chinese University of Hong Kong
  • The University of New South Wales press Limited
  • Thermo Fisher Scientific Inc
  • TrivarX Ltd
  • U.S. Army Medical Research and Development Command
  • Universal Biosensors Inc
  • Universidade Feevale
  • University of California Santa Cruz
  • University of Central Florida
  • University of Colorado
  • University of Colorado Denver
  • University of Edinburgh
  • University of Florida
  • University of Illinois at Chicago
  • University of Kentucky
  • University of Massachusetts Lowell
  • University of North Carolina at Chapel Hill
  • University of North Dakota
  • University of Queensland
  • University of Texas at Arlington
  • University of Washington
  • UrSure Inc
  • Vanderbilt University
  • Vanteres Pte Ltd
  • Virginia Polytechnic Institute and State University
  • Vyant Bio Inc
  • Withings SA